Thomas Catinazzo - Jul 28, 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Chief Financial Officer
Signature
/s/ Brian Adams, as Attorney-in-Fact
Stock symbol
RLAY
Transactions as of
Jul 28, 2025
Transactions value $
-$74,000
Form type
4
Date filed
7/30/2025, 04:54 PM
Previous filing
Apr 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Catinazzo Thomas Chief Financial Officer C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE /s/ Brian Adams, as Attorney-in-Fact 2025-07-30 0001818261

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$6.36K -1.7K -0.48% $3.74 354K Jul 28, 2025 Direct F1, F2
transaction RLAY Common Stock Sale -$67.6K -18.4K -5.2% $3.68 335K Jul 29, 2025 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,724 shares of restricted stock units ("RSUs") on July 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 200,516 shares underlying RSUs.
F3 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,393 shares of RSUs on July 28, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F4 Includes 158,123 shares underlying RSUs.